December’s IPO frenzy features 15 IPOs (mainboard + SME) opening/closing/listing in the next 8 days, with GMPs hinting up to 41–44% listing premiums for high-demand names like Meesho while smaller issues show muted response. From Dec 5 closures to Dec 12–15 listings, here’s the complete tracker for retail/HNI investors amid peak season momentum.
Hottest GMP Gainers: 40%+ Listing Potential
Grey market signals strongest debuts:
| IPO Name | GMP (₹) | Est. % Gain | Price Band | Listing Date |
|---|---|---|---|---|
| Meesho (Mainboard) | ₹49.5 | 44% | ₹105–115 | Dec 10 |
| Aequs (Mainboard) | ₹41 | 33% | ₹118–124 | Dec 10 |
| Corona Remedies (Mainboard) | ₹365 | 31–35% | ₹1008–1062 | Dec 15 |
| Vidya Wires (SME) | ₹5.5 | 10% | ₹52 | Dec 10 |
Meesho dominates Day 2 sub at 235–300%, GMP climbing to 44%.
Full 8-Day IPO Calendar (Dec 5–12)
Closing Today (Dec 5):
- Meesho (e-commerce, hot)
- Neochem Bio (SME, GMP ₹98, 15x sub)
Opening Dec 8–10:
| Date | Mainboard | SME |
|---|---|---|
| Dec 8 | Corona Remedies (₹655 Cr pharma OFS) | KV Toys (₹40 Cr), Prodocs Solutions |
| Dec 9 | Wakefit Innovations (consumer) | Riddhi Display (₹24 Cr) |
| Dec 10 | Aequs (aerospace) | Vidya Wires, Unisem Agritech |
Listings Dec 8–15: Helloji Holidays, Invicta Diagnostic, Pajson Agro, Speb Adhesives
Live GMP & Subscription Tracker
| IPO | GMP | Sub % (Day) | Kostak (₹) | Status |
|---|---|---|---|---|
| Meesho | ₹49.5 (44%) | 235–300% (D2) | ₹80–100 | Closing Dec 5 |
| Aequs | ₹41 (33%) | Opening Dec 8 | – | High interest |
| Neochem Bio (SME) | ₹98 | 15x | ₹150 | Closing today |
| Exato Tech (recent) | Listed +90% | 880x | – | Success benchmark |
Flat/Zero GMP: Speb Adhesives (₹0–2), some micro-SMEs
Investor Playbook: Next 8 Days
- Dec 5: Final Meesho/Neochem bids—GMP >40% signals strong list.
- Dec 6–7: Allotments for closing IPOs.
- Dec 8: Corona Remedies/KV Toys open—watch Day 1 sub.
- Dec 10: Meesho/Aequs peak listings—book 30%+ GMP profits.
- Retail quota: Apply early; HNI oversub likely on hot names.
GMP Caveat: Unofficial indicator; actual listing varies 10–20%.
Sector Hotspots: Pharma, E-comm Lead
- Pharma: Corona Remedies (₹655 Cr OFS) GMP ₹365
- E-commerce: Meesho subscription frenzy
- Aerospace: Aequs 33% GMP
- SMEs: Volume play with 10–20x sub potential
December closes strong with 9+ new issues post-Meesho.
